REG - SkinBioTherapeutics - Director/PDMR Shareholding

SkinbiotherapeuticsAnnouncement

09/03/2023 17:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230309:nRSI4961Sa&default-theme=true

RNS Number : 4961S  SkinBioTherapeutics PLC  09 March 2023

9 March 2023

SkinBioTherapeutics plc

("SBTX" or the "Company")

Director Bed & ISA Dealings

SkinBioTherapeutics plc (AIM: SBTX), the life science company focused on skin
health, announces that it received notification on 9 March 2023 that Manprit
Randhawa, CFO and PDMR, sold 89,472 ordinary shares of 1p each in the Company
("Ordinary Shares") and repurchased 86,387 Ordinary Shares into Mr Randhawa's
ISA account.  Following this transaction Manprit Randhawa's beneficial
interest in the Company shares has decreased from 156,250 to 153,165 ordinary
shares, with the variance owing to commissions and costs of the transactions.

Details of PDMR transaction

  1   Details of the person discharging managerial responsibilities / person closely
      associated
 a)   Name                                                         Manprit Randhawa
 2    Reason for the notification
 a)   Position/status                                              PDMR (CFO)
 b)   Initial notification /Amendment                              Initial notification
 3    Details of the issuer, emission allowance market participant, auction
      platform, auctioneer or auction monitor
 a)   Name                                                         SkinBioTherapeutics plc
 b)   LEI                                                          213800YMQOCB23FX6I06
 4    Details of the transaction(s): section to be repeated for (i) each type of
      instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted
 a)   Description of the financial instrument, type of instrument  Ordinary Shares in SkinBioTherapeutics plc

      Identification code                                          GB00BF33H870

 b)   Nature of the transaction                                    Sale and purchase of ordinary shares
 c)   Price(s) and volume(s)
                                                                                     Price(s)             Volume(s)
                                                                                     Sale at 22.75 p      89,472
                                                                                     Purchase at 22.75 p  86,387

 d)   Aggregated information

      - Aggregated volume                                          n/a

      - Price

 e)   Date of the transactions                                     6 March 2023
 f)   Place of the transaction                                     N/A

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHQKLFBXXLEBBQ